Korea Biomedical Review | IVI Director General highlights balancing vaccine sovereignty with joint global response
Korea Biomedical Review | IVI Director General highlights balancing vaccine sovereignty with joint global response
2023. 9. 13, 코리아 바이오메디칼 리뷰
After the devastating impacts of the Covid-19 pandemic, many countries are striving to achieve vaccine sovereignty and Korea is one of them. However, the WHO Pandemic Treaty which is carded to be further discussed next week in a UN High Level Meeting, has drawn the attention of Korean vaccine manufacturers due to a contentious clause regarding benefit sharing based on a joint global response in pandemics.
